Virtu Financial’s INmune Bio INMB Stock Holding History

Virtu Financial’s Portfolio INMB Stock Details INMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$123K	Buy	+75,212	New	+$104K	﹤0.01%	1066
2026 Q1	–	Sell	-20,388	Closed	-$32K	–	1955
2025 Q4	$32K	Buy	+20,388	New	+$36.4K	﹤0.01%	1356
2025 Q3	–	Sell	-40,231	Closed	-$93K	–	1759
2025 Q2	$93K	Buy	+40,231	New	+$295K	﹤0.01%	1047
2022 Q1	–	Sell	-24,364	Closed	-$249K	–	1737
2021 Q4	$249K	Buy	+24,364	New	+$361K	0.03%	731
2021 Q3	–	Sell	-10,530	Closed	-$185K	–	1711
2021 Q2	$185K	Buy	+10,530	New	+$142K	0.02%	1031

Other funds holding INMB

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Virtu Financial's INMB Position: Q2 2026 in Review

Virtu Financial opened a new position in INmune Bio (INMB) in Q2 2026: 75,212 shares worth $123K. The stake represents ﹤0.01% of the portfolio and ranks #1066 among its holdings. This is a return to the name: Virtu Financial previously reported a position in INMB as recently as Q4 2025.

Virtu Financial first reported a position in INMB in Q2 2021 and has held it in 5 quarters since. The position peaked at $249K in Q4 2021. 82 funds tracked by Wall St. Rank hold INMB as of Q2 2026.

Virtu Financial held 75,212 shares of INmune Bio worth $123K as of Q2 2026.
INmune Bio was a new Virtu Financial position in Q2 2026.
INmune Bio made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1066 holding.
Virtu Financial first reported a position in INmune Bio in Q2 2021 and has held it in 5 quarters since.
Virtu Financial's INmune Bio position peaked at $249K in Q4 2021.
82 funds tracked by Wall St. Rank held INmune Bio as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.